Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02803970

KOrean Borderline Ovarian Tumor (KOBOT) Registry

The aim of this study is to collect data on Korean patients with borderline ovarian tumors.

Recruiting

Interested in participating?

Request Info

Key information

About this study

The researchers retrospectively collected data on Korean patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea. And the researchers prospectively will collect data on all Korean patients with BOTs at institutions where placed in the Republic of Korea since March, 2015. If patients agree to participate in this KOBOT registry, patient's data (such as age, body mass index, preoperative findings, laboratory findings, radiologic findings, operative findings, pathologic findings, postoperative findings) will be collected in a research database. The research database will be updated, every 6 month, to include data on patient's disease outcome and follow-up care. Although most data will be collected form the medical record, patient may agin be contacted so that researchers can collection some data if it is not in the medical record.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea.
  • All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015

Exclusion criteria

  • Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis

Treatment and study plan

Primary outcomes

  1. Recurrence-free survival

    Time frame: up to 100 months

Study contacts

Contact information is provided by the study sponsor or research team.

Taejong Song, MD,PhD

CONTACT

[email protected]

82-2-2001-2582

Sponsors and collaborators

Lead sponsor

Kangbuk Samsung Hospital

Other

Registry information

Official study title

Establishing the Registry of Korean Patients With Borderline Ovarian Tumors

Acronym: KOBOT

Important dates

Study start
1994
Primary completion
2040
Study completion
2040
First posted
Jun 17, 2016
Registry last updated
Apr 3, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.